Comments on: Maintenance Sorafenib Improves Long-Term Survival Post-HSCT in AML Subgroup https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/acute-myeloid-leukemia-aml-sorafenib-hsct-stem-cell-survival-improves-long-term/ Sat, 14 Oct 2023 02:40:39 +0000 hourly 1 https://wordpress.org/?v=6.4.3